Predicting Durable Clinical Benefits of Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer: A Nomogram Based on CT Imaging and Immune Type-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predicting Durable Clinical Benefits of Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer: A Nomogram Based on CT Imaging and Immune Type

Published:2024-08 Issue: Volume: Page:
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Deng Liangna,Zhang Mingtao,Zhu Kaibo,Ren Jialiang,Zhang Peng,Zhang Yuting,Jing Mengyuan,Han Tao,Zhang Bin,Zhou Junlin^ORCID

Funder

Lanzhou University Second Hospital

National Natural Science Foundation of China

Natural Science Foundation of Henan Province

Publisher

Elsevier BV

Reference36 articles.

1. Advanced-stage non-small cell lung cancer: advances in thoracic oncology 2018;Remon;J Thorac Oncol,2019

2. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

3. Turning tumors from cold to inflamed to improve immunotherapy response;Gerard;Cancer Treat Rev,2021

4. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities;Kim;Nat Rev Drug Discov,2022

5. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial;Paz-Ares;Lancet,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP